Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;
Ann Hepatol. 2024;29:
Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c
Hirsh D. Trivedi; Qua Tran; Zachary Fricker; Michael P. Curry; Jonathan X. Li; Michelle Lai;
Ann Hepatol. 2023;28: